Impact of serum 25-hydroxyvitamin D on cardiac prognosis in Chinese patients with heart failure - PubMed (original) (raw)
. 2019 Jul 28;122(2):162-171.
doi: 10.1017/S0007114519000795. Epub 2019 Jul 24.
Affiliations
- PMID: 30935437
- DOI: 10.1017/S0007114519000795
Impact of serum 25-hydroxyvitamin D on cardiac prognosis in Chinese patients with heart failure
Ya-Min Hou et al. Br J Nutr. 2019.
Abstract
There is growing evidence that suggests the association of vitamin D status with the development and progression of heart failure (HF). The objective of the present study is to assess the impact of concentration of serum 25-hydroxyvitamin D (25(OH)D) on cardiac prognosis in patients with HF. Between 1 January 2015 and 31 December 2016, we consecutively recruited patients with HF. Patients were followed prospectively for a median duration of 1 year. Serum concentration of 25(OH)D was measured with competitive chemiluminescent immunoassay. The endpoints were cardiac events, including CVD death and rehospitalisation for worsening HF. Univariate and multivariable adjustments were performed with Cox proportional-hazard regression analyses. The 25(OH)D concentration was obtained in 343 patients with a median value of 17·4 (interquartile range 12·6-23·4) ng/ml. There were 102 cardiac events, including forty-three deaths and fifty-nine rehospitalisations. Multivariate Cox hazard analysis found that the serum concentration 25(OH)D was independently associated with cardiac events (hazard ratio 0·93, 95 % CI 0·88, 0·97) and CVD mortality (hazard ratio 0·83; 95 % CI 0·77, 0·89) after adjustment for confounding factors. We divided the HF patients into four groups according to the 25(OH)D quartiles. Kaplan-Meier analysis found that the patients with lower serum 25(OH)D concentration had a higher risk of cardiac events or CVD mortality than those with high serum 25(OH)D concentration (log-rank test P < 0·001 and P = 0·032). Decreased serum concentrations of 25(OH)D were associated with cardiac prognosis and CVD mortality in a Chinese population with HF independent of other baseline HF markers.
Keywords: 25-Hydroxyvitamin D; Cardiac events; Chinese; Heart failure; Prognosis; Vitamin D.
Similar articles
- Serum parathyroid hormone and 25-hydroxyvitamin D concentrations and risk of incident heart failure: the Multi-Ethnic Study of Atherosclerosis.
Bansal N, Zelnick L, Robinson-Cohen C, Hoofnagle AN, Ix JH, Lima JA, Shoben AB, Peralta CA, Siscovick DS, Kestenbaum B, de Boer IH. Bansal N, et al. J Am Heart Assoc. 2014 Dec 2;3(6):e001278. doi: 10.1161/JAHA.114.001278. J Am Heart Assoc. 2014. PMID: 25468653 Free PMC article. - Serum 25-hydroxyvitamin D concentration and mortality from heart failure and cardiovascular disease, and premature mortality from all-cause in United States adults.
Liu L, Chen M, Hankins SR, Nùñez AE, Watson RA, Weinstock PJ, Newschaffer CJ, Eisen HJ; Drexel Cardiovascular Health Collaborative Education, Research, and Evaluation Group. Liu L, et al. Am J Cardiol. 2012 Sep 15;110(6):834-9. doi: 10.1016/j.amjcard.2012.05.013. Epub 2012 Jun 2. Am J Cardiol. 2012. PMID: 22658246 - Vitamin D deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fraction.
Nolte K, Herrmann-Lingen C, Platschek L, Holzendorf V, Pilz S, Tomaschitz A, Düngen HD, Angermann CE, Hasenfuß G, Pieske B, Wachter R, Edelmann F. Nolte K, et al. ESC Heart Fail. 2019 Apr;6(2):262-270. doi: 10.1002/ehf2.12413. Epub 2019 Feb 19. ESC Heart Fail. 2019. PMID: 30784226 Free PMC article. - Vitamin D status and outcomes in heart failure patients.
Liu LC, Voors AA, van Veldhuisen DJ, van der Veer E, Belonje AM, Szymanski MK, Silljé HH, van Gilst WH, Jaarsma T, de Boer RA. Liu LC, et al. Eur J Heart Fail. 2011 Jun;13(6):619-25. doi: 10.1093/eurjhf/hfr032. Epub 2011 May 4. Eur J Heart Fail. 2011. PMID: 21543375 Clinical Trial. - Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies.
Wang L, Song Y, Manson JE, Pilz S, März W, Michaëlsson K, Lundqvist A, Jassal SK, Barrett-Connor E, Zhang C, Eaton CB, May HT, Anderson JL, Sesso HD. Wang L, et al. Circ Cardiovasc Qual Outcomes. 2012 Nov;5(6):819-29. doi: 10.1161/CIRCOUTCOMES.112.967604. Epub 2012 Nov 13. Circ Cardiovasc Qual Outcomes. 2012. PMID: 23149428 Free PMC article. Review.
Cited by
- A Review: Highlighting the Links between Epigenetics, COVID-19 Infection, and Vitamin D.
Foolchand A, Mazaleni S, Ghazi T, Chuturgoon AA. Foolchand A, et al. Int J Mol Sci. 2022 Oct 14;23(20):12292. doi: 10.3390/ijms232012292. Int J Mol Sci. 2022. PMID: 36293144 Free PMC article. Review. - Is vitamin D deficiency a risk factor for all-cause mortality and rehospitalization in heart failure patients?: A systematic review and meta-analysis.
Wang X, Wang J, Gao T, Sun H, Yang B. Wang X, et al. Medicine (Baltimore). 2022 Jul 15;101(28):e29507. doi: 10.1097/MD.0000000000029507. Medicine (Baltimore). 2022. PMID: 35839043 Free PMC article. - Role of vitamin D in preventing of COVID-19 infection, progression and severity.
Ali N. Ali N. J Infect Public Health. 2020 Oct;13(10):1373-1380. doi: 10.1016/j.jiph.2020.06.021. Epub 2020 Jun 20. J Infect Public Health. 2020. PMID: 32605780 Free PMC article. Review. - Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths.
Grant WB, Lahore H, McDonnell SL, Baggerly CA, French CB, Aliano JL, Bhattoa HP. Grant WB, et al. Nutrients. 2020 Apr 2;12(4):988. doi: 10.3390/nu12040988. Nutrients. 2020. PMID: 32252338 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous